Gilead Sciences (GILD) PT Lowered to $75 at Mizuho Securities on magrolimab Risks

February 7, 2022 8:48 AM EST Send to a Friend
Mizuho Securities analyst Salim Syed lowered the price target on Gilead Sciences ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login